Dr. Steven Howard has expertise in the treatment of patients with brain tumors. His research focuses on the clinical application of new radiation techniques and radiation-drug combinations to improve outcomes for brain tumor patients. Dr. Howard has received numerous awards and honors for his work in Radiation Oncology.
Dr. Cooley is a clinical associate professor in the Department of Human Oncology (DHO). The DHO is one of the few centers in the region offering both low-dose-rate and high-dose-rate prostate brachytherapy. Two decades ago, prostate brachytherapy showed superior PSA control rates. With further advances in dosing, fractionation and MRI-based planning, results are even better.
Dr. Baschnagel is actively involved in translational and clinical research. I work closely with basic scientists, physicists and clinicians with the goal of fostering new ideas and translating research findings into the clinic. He has experience studying combinations of radiation and novel radiosensitizers and biomarkers of treatment response in patients and in preclinical models. His current work focuses on improving treatment of non-small cell lung cancer with a focus on brain metastases. He is actively involved at the regional and national level, and I am site PI for multiple national clinical studies here at UW.